Dimethylphenylpiperazinium
Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype.[1] One of the earliest reports on the pharmacology of DMPP, describing it as a ganglion-stimulating, hypertensive agent, came from Graham Chen and his co-workers at Parke, Davis & Co.[2]
Identifiers | |
---|---|
IUPAC name
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H19N2 |
Molar mass | 191.29 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
See also
- Phenylpiperazine
References
- Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. doi:10.1016/j.brainres.2004.05.085. PMID 15276888.
- G. Chen, R. Portman and A. Wickel (1951) J. Pharmacol. Exp. Ther. 103 (1951).
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.